Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen Pharmacare Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 50.55B | 11.3x | -1.41 | ZAC 11,380 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.6% Upside | Upgrade to Pro+ | |
Life Healthcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 19.51B | -21.1x | 0.16 | ZAC 1,353 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.7% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 16.44B | 11.1x | 0.45 | ZAC 1,349 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
Netcare | Johannesburg | Healthcare | Healthcare Providers & Services | ZAR 16.44B | 11.1x | ZAC 8,900 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Adcock Ingram Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 7.46B | 11.2x | -1.12 | ZAC 5,083 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.8% Upside | Upgrade to Pro+ | |
Ascendis Health Ltd | Johannesburg | Healthcare | Pharmaceuticals | ZAR 531.89M | 29.8x | 0.19 | ZAC 85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Numeral | Johannesburg | Healthcare | Biotechnology & Medical Research | ZAR 243.67M | 10x | ZAC 2 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Cilo Cybin Holdings | Johannesburg | Healthcare | Pharmaceuticals | ZAR 209.50M | -345.9x | 1.34 | ZAC 295 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |